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Summary
A limited number of evolutionarily conserved signal
transduction pathways are repeatedly reused during
development to regulate a wide range of processes.
Here we describe a new negative regulator of JAK/
STAT signaling and identify a potential mechanism
by which the pleiotropy of responses resulting from
pathway activation is generated in vivo. As part of a
genetic interaction screen, we have identified Ken &
Barbie (Ken) [1], which is an ortholog of the mamma-
lian proto-oncogene BCL6 [2], as a negative regulator
of the JAK/STAT pathway. Ken genetically interacts
with the pathway in vivo and recognizes aDNAconsen-
sus sequence overlapping that of STAT92E in vitro.
Tissue culture-based assays demonstrate the exis-
tence of Ken-sensitive and Ken-insensitive STAT92E
binding sites, while ectopically expressed Ken is suffi-
cient to downregulate a subset of JAK/STAT pathway
target genes in vivo. Finally, we show that endoge-
nousKen specifically represses JAK/STAT-dependent
expression of ventral veins lacking (vvl) in the poste-
rior spiracles. Ken therefore represents a novel regula-
tor of JAK/STAT signaling whose dynamic spatial and
temporal expression is capable of selectivelymodulat-
ing the transcriptional repertoire elicited by activated
STAT92E in vivo.
Results and Discussion
Ken Genetically Interacts with JAK/STAT Signaling
Analysis of phenotypes associated with mutations in
Drosophila JAK/STAT pathway components have iden-
tified a wide variety of requirements for the pathway dur-
ing embryonic development and in adults (reviewed in
[3, 4]). What is less clear is how the repeated stimulation
of a single pathway is able to generate this pleiotropy of
developmental functions. In order to identify modulators
of JAK/STAT signaling that may be involved in this pro-
cess, we undertook a genetic screen for modifiers of the
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of the pathway ligand Unpaired (Upd) in the developing
eye imaginal disc. Such misexpression by GMR-updD30
results in overgrowth of the adult eye, a phenotype sen-
sitive to the strength of pathway signaling activity [5].
With this assay, one genomic region, defined by
Df(2R)Chig320, was found to enhance the GMR-updD30-
induced eye overgrowth phenotype. Of the genes de-
leted by Df(2R)Chig320, only mutations in ken showed
consistent and reproducible enhancement of the pheno-
type (Figures 1A and 1B and not shown). In addition,
other dominant phenotypes induced by transgene ex-
pression from the GMR promoter are not modulated
by ken mutations, indicating that Ken is unlikely to inter-
act with the misexpression construct used (not shown).
The enhancement of the GMR-updD30 phenotype af-
ter removal of one copy of ken implies that Ken normally
functions antagonistically to JAK/STAT signaling. We
therefore tested phenotypes associated with mutations
in other pathway components to establish the reliability
of this initial observation. Consistent with this, genetic
interaction assays between ken mutations and the
hypomorphic loss-of-function allele stat92EHJ [6] show
a reduction in the frequency of wing vein defects nor-
mally associated with this stat92E allele (Figures S1A
and S1B in the Supplemental Data available with this ar-
ticle online). Moreover, the degree of suppression is
consistent with the strength of ken alleles tested (Sup-
plemental Data and Table S1). Similarly, the frequency
of ‘‘strong’’ posterior spiracle phenotypes caused by
the dome367 allele of the pathway receptor is also re-
duced when crossed to ken alleles or the Df(2R)Chig320
deficiency, with a concomitant increase in ‘‘weak’’ phe-
notypes (Table S2 and Figures S1C–S1E).
Thus, multiple independent ken alleles all modify di-
verse phenotypes caused by both gain- and loss-of-
function mutations in multiple JAK/STAT pathway com-
ponents. Each of these components acts at different
levels of the signaling cascade and show interactions
indicating that Ken consistently acts as an antagonist
of the pathway.
The Ken Locus
The ken locus contains three exons encoding a 601 aa
protein (Figure 1C) [1, 7, 8]. Ken possesses an N-terminal
BTB/POZ domain between aa 17 and 131 and three
C-terminal C2H2 zinc finger motifs from aa 502 to 590
(Figure 1D). Strikingly, a number of Zn finger-containing
proteins that also contain BTB/POZ domains have also
been shown to function as transcriptional repressors—
often via the recruitment of corepressors such as
SMRT, mSIN3A, N-CoR, and HDAC-1 [9, 10].
Searches for proteins similar to Ken identified homo-
logs in Drosophila pseudoobscura and the mosquito
Anopheles gambiae. In vertebrates, human B-Cell Lym-
phoma 6 (BCL6) [11] was the closest full-length homo-
log. Drosophila Ken and human BCL6 share the same
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ure 1D) [12]. Proteins listed as potential vertebrate ho-
mologs of Ken in Flybase (http://flybase.bio.indiana.
edu) are more distantly related (Figure 1E).
Expression of ken was also examined during develop-
ment, where it is detected in a dynamic pattern from
newly laid eggs, throughout embryogenesis (Figures
2A–2E), and in imaginal discs (Figures 2H–2J). As such,
endogenous Ken is present in all tissues and stages in
which genetic interactions were observed.
Figure 1. Genetic Interactions between ken and the JAK/STAT Path-
way
(A and B) Dorsal views of adultGMR-updD30 flies either wild-type (A)
or heterozygous for the ken1 allele (B). Note the additional over-
growth in the eye caused by the removal of one copy of ken (arrow
in B).
(C) The ken genomic region is flanked by the thiolase and TM4SF
loci. The position of P element insertions that give rise to the alleles
used are shown (not to scale). Coding regions are shown in gray and
include three amino acids encoded by exon 1.
(D) The predicted Ken protein contains an N-terminal BTB/POZ do-
main and three C-terminal zinc fingers. The degree of identity (sim-
ilarity) to human BCL6 is shown.
(E) A phylogenetic tree showing the relationship of human (Hs),
mouse (Mm), and rat (Rn) BCL6 genes to BAZF and the related inver-
tebrate Ken-like proteins from Drosophila melanogaster (Dm), D.
pseudobscura (Dp), and mosquito (Ag). More distantly related genes
from human, mouse, and C. elegans (Ce) are also shown.Ken Binds to a DNA Sequence that Overlaps that
of STAT92E
Given the presence of potentially DNA binding Zn finger
domains and the nuclear localization of GFPKen (Fig-
ures 2K–2N), we set out to determine the DNA binding
properties of Ken by using an in vitro selection technique
termed SELEX (systematic evolution of ligands by expo-
nential enrichment) [13]. With a GST-tagged Ken Zn fin-
ger domain and a randomized oligonucleotide library,
ten successive rounds of selection were undertaken.
Sequencing of the resulting oligonucleotide pool and
alignment of 43 independent clones showed that all re-
covered plasmids were unique and each contained
one, or occasionally two, copies of the motif GNGAAAK
(K = G/T; Table S3).
To confirm the SELEX results, we expressed GFPKen
in tissue culture cells and used these for electromobility
shift assays (EMSA). A radioactively labeled probe con-
taining the wild-type (wt) consensus binding site GAG
AAAG gave a specific band, which can be supershifted
by an anti-GFP antibody (Figure 3A) and therefore repre-
sents a GFPKen/DNA complex. In order to identify posi-
tions essential for binding, we used a competition assay
in which unlabeled oligonucleotides containing single
substitutions in each position from 1 to 7 (Table S3)
were added to binding reactions. 10-fold excess of unla-
beled wild-type consensus oligonucleotide greatly di-
minished the intensity of the GFPKen band, while 50-
and 100-fold excess totally blocked the original signal
(Figure 3B). By contrast, competition with unlabeled
m3 oligonucleotides containing a G to A substitution at
position 3 failed to significantly reduce the intensity of
the band even at 100-fold excess (Figure 3B). With this
approach, the positions 1 and 7 are found dispensable
for DNA binding, whereas the central GAAA core is
absolutely required (Figure 3B). Similar results were
obtained with the converse experiment with labeled mu-
tant probes, although in this case the wt probe produces
a stronger signal than the m1 and m7 mutant oligo-
nucleotides (not shown). Taken together, these experi-
ments not only define the core sequence for Ken bind-
ing, but also demonstrate the specificity of Ken as
a site-specific DNA binding molecule.
Interestingly, the core consensus bound by Ken is
very similar to that identified for human BCL6, with the
Zn fingers of the latter binding to a DNA sequence con-
taining a core GAAAG motif [12, 14].
Ken Selectively Regulates JAK/STAT Reporters
in Cell Culture
One initial observation made is that the core GAAA es-
sential for Ken binding overlaps the sequence recog-
nized by STAT92E (Figure 3C) [15]. Consistent with this
overlap, a 100-fold excess of unlabeled oligonucleotide
containing the STAT92E consensus is sufficient to fully
compete for Ken in EMSA assays (Figure 3B). Given
this finding, we hypothesize that the negative regulation
of JAK/STAT signaling by Ken observed in genetic inter-
action assays may occur via a mechanism of competi-
tive DNA binding site occupation. Due to the incomplete
overlap between the STAT92E and Ken core sequences
(Figure 3C), this hypothesis also implies the existence
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82Figure 2. ken Expression during Develop-
ment
(A–F) Embryonic ken expression. In the stage
3/4 blastoderm (A), low levels of maternally
supplied ken are detected that resolve to
two narrow stripes of expression (at 64%
and 16% of egg length) by stage 5 (B). At the
onset of gastrulation, the anterior stripe im-
mediately posterior to the cephalic furrow
(arrowheads), weakens, while the posterior
domain coalesces (C). ken is then expressed
in the presumptive hindgut/posterior spiracles
and maintains its relative position within the
extending germband. By stage 13, only the
posterior spiracle primordia express ken (D).
At stage 15 and later, ken is visible in the fore-
gut and posterior spiracles, within the poste-
rior region of the dorsal tracheal trunk, and
in segmentally repeated stripes within the epi-
dermis (E).
(F and G) Dorsal views of stage 13 embryos
showing expression of ken (F) and upd (G).
Both ken and upd are expressed in the pre-
sumptive posterior spiracles, though the re-
gion of upd expression (asterisks) is smaller
and occupies only the center of the primordia.
Arrow marks the expression of upd in the
hindgut.
(H–J) ken expression in eye-antennal (H), leg
(I), and wing (J) imaginal discs from late third
instar larvae.
(K–N) Intracellular localization of GFPKen
expressed by sgs3-GAL4 in the third instar
salivary gland. GFPKen (green) is primarily
located in the nuclei identified by the DNA
stain DRAQ5 (blue) and is enriched at the
cell membrane. Cell morphology is visualized
by TRITC-phalloidin (red), which stains sub-
cortical F-actin. All three channels are shown
separately (K–M) and merged (N).of STAT92E DNA binding sites to which both STAT92E
and Ken could bind (STAT+/Ken+) as well as sites
with which Ken cannot associate (STAT+/Ken2) (Fig-
ure 3D).
To test this hypothesis, we set up a cell culture-based
assay by using a luciferase-expressing reporter contain-
ing four STAT92E binding sites (Figure 3D) originally
identified in the promoter of the Draf locus [16]. In addi-
tion to this STAT+/Ken+ wild-type reporter, we also gen-
erated STAT+/Ken2 and STAT2/Ken2 variants identical
but for the binding sequences shown in Figure 3D.
When transfected into the hemocyte-like Kc167 Dro-
sophila cell line, both STAT+/Ken+ and STAT+/Ken2 re-
porters showed strong stimulation upon coexpression
with the pathway ligand Upd (Figure 3E), an assay previ-
ously shown to require an intact JAK/STAT cascade
[17]. When cotransfected with KenGFP, the activity of
the STAT+/Ken+ reporter was reduced (Figure 3E), an ef-
fect reproduced in three independent experiments with
both KenGFP and Ken (not shown). While the reduction
in reporter activity for the STAT+/Ken+ assay shown is
statistically significant (p = 0.007), the STAT+/Ken2 re-
porter was unaffected by the coexpression of Ken
(Figure 3E). Reporters containing binding sites mutated
to prevent binding of both STAT92E and Ken (STAT2/
Ken2) showed no activation after pathway stimulation
and did not respond to Ken (Figure 3E).These results indicate that Ken functions as a tran-
scriptional repressor in this cell-culture system and
shows that this effect is specific to the DNA sequence
determined by SELEX and EMSA. This result is also con-
sistent with a recent whole-genome RNAi-based screen,
which used a reporter containing STAT+/Ken+ binding
sites and includes Ken among the list of JAK/STAT reg-
ulators identified [18]. In addition, recent reports have
also demonstrated BCL6 binding to STAT6 sites in vitro
and have shown that BCL6 can act as a repressor of
STAT6-dependent target gene expression in cell culture
[19, 20]. Although this repression is mediated by the
binding to corepressors to the BTB/POZ domain of
BCL6 [9], no link between BCL6 and STAT activity has
been demonstrated in vivo.
Finally, it should also be noted that both the STAT+/
Ken+ and STAT+/Ken2 reporters contain additional
GAAA sequences that are not part of the characterized
STAT92E binding sequences. However, despite the
presence of these potential Ken binding sites within 15
bp of the STAT92E site, Ken expression did not affect
the STAT+/Ken2 reporter (Figure 3E), suggesting that
Ken may require STAT92E to influence gene expression.
Although we have not been able to demonstrate a direct
association between Ken and STAT92E (not shown), we
cannot exclude this possibility, and further analysis re-
mains to be undertaken.
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says
(A) GFPKen and GFP were derived from S2R+
cell lysates. GFPKen specifically binds to the
radioactively labeled probe containing the
GAGAAAG consensus sequence. The result-
ing band (arrowhead) can be supershifted
by anti-GFP antibody.
(B) Unlabeled binding site competition as-
says. Wild-type oligonucleotides include the
GAGAAAG consensus. m1, m3, and m7 con-
tain G to A substitutions in positions 1, 3, and
7, respectively. m4, m5, and m6 have A to T
substitutions in the corresponding positions.
Loss of the specific band indicates that the
indicated excess of unlabeled mutant oligo-
nucleotides are capable of binding to Ken.
(C) A schematic representation of STAT92E
(underlined) and Ken (bold) consensuses
binding sites.
(D) Schematic of the 2x2DrafLuc reporter
plasmids showing the four identical STAT92E
binding domains (larger blocks) located up-
stream of the firefly luciferase ORF. The se-
quences of the STAT92E binding regions
are shown, with the minimal STAT92E binding
sequence underlined and the minimal Ken
binding sequence shown in bold. Not shown
to scale.
(E) Effects of cotransfection of Upd- and
KenGFP-expressing plasmids on luciferase
reporter activity. Drosophila Kc167 cells were
cotrasfected with the indicated reporters (for
sequences, see [D]). Values represent the
ratio of firefly luciferase to a constitutively ex-
pressedRenilla luciferase transfection control
and are shown as multiples of the unstimu-
lated cells. One representative experiment
undertaken in sextuplicate is shown. Error
bars show standard deviations, and p values
are calculated by a Student’s t test comparing
Upd-expressing with Upd- and Ken-express-
ing cells.Ken Is Sufficient to Downregulate a Subset
of JAK/STAT Pathway Target Genes In Vivo
Having established that Ken functions at the level of
DNA binding in cell culture, we asked whether Ken
also acts as a transcriptional repressor of JAK/STAT
pathway target genes in vivo. For this, we examined
the effect of ectopically expressed Ken on the expres-
sion of putative JAK/STAT pathway target genes and,
given the high levels of maternally loaded STAT92E
present at blastoderm stage, we focused on targets
expressed later in embryogenesis. These include the
hindgut-specific expression of vvl [21], the expression oftrachealess (trh) and knirps (kni) in the tracheal placodes
[22], and the dynamic expression of socs36E throughout
the embryo [23].
First, we addressed the effect of Ken on trh, expres-
sion of which precedes the formation of the tracheal
pits in the embryonic segments T2 to A8 (Figures 4A
and 4D) [22]. Levels of trh are greatly reduced in em-
bryos uniformly misexpressing Ken driven by thedaugh-
terless-GAL4 (da-GAL4) line (Figure 4B). Many tracheal
placodes express little or no trh, and tracheal pits fail
to form even in the presence of residual trh (Figure 4E).
Similar effects are seen in updOS1A mutant embryos
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(A–F) trh expression in stage 10–11 embryos
of the indicated genotypes.
(A) Wild-type embryos show expression in
ten tracheal placodes and the presumptive
salivary gland.
(B) Inda-GAL4/UAS-ken (da> ken), only weak
staining is seen in a few tracheal placodes.
(C) Low levels of trh expression are also ob-
served in embryos mutant for the strong
updOS1A allele.
(D–F) High-magnification views of the first tra-
cheal placode. Tracheal pits formed in wild-
type embryos (arrows in [D]) are missing in
both da > ken (E) and updOS1A mutants (F).
(G and H) Stage 10/11 embryos stained with
anti-Knirps antibody. Staining in the tracheal
pits typical for wild-type embryos (G) is not
detectable in embryos expressing da > ken
(H).
(I–L) Expression of socs36E in the hindgut of
stage 13 embryos (arrowheads). Expression
in the wild-type embryo (I) is similar to that in
da > ken embryos (J). By contrast, signifi-
cantly reduced levels of socs36E are detected
in the da > domeDCyt (K) and updOS1A mutant
embryos (L).lacking all pathway activity (Figures 4C and 4F). Like-
wise, downregulation of Kni expression is also observed
in embryos misexpressing ken (Figures 4G and 4H).
These results show that both endogenous trh and kni
are downregulated by ectopically expressed Ken.
We then tested whether Ken can modulate the ex-
pression of socs36E, a Drosophila homolog of mouse
SOCS-5. socs36E expression closely mirrors that of
upd, showing JAK/STAT pathway-dependent upregula-
tion in segmentally repeated stripes, tracheal pits, and
the hindgut [23]. By contrast to trh and kni, ectopically
expressed Ken does not affect any aspect of socs36E
transcription (Figures 4I and 4J and not shown). How-
ever, controls expressing a dominant-negative form of
the pathway receptor DomeDCyt [22], using the same
Gal4 driver line, show a strong downregulation of
socs36E (Figure 4K), an effect reproduced by the com-
plete removal of all JAK/STAT pathway activity by the
updOS1A allele (Figure 4L).
Taken together, these results illustrate that ectopic
expression of Ken during Drosophila development is
sufficient to downregulate the expression of only a sub-
set of putative JAK/STAT pathway target genes.
Ken Regulates STAT92E-Induced vvl
As part of our analysis, we tested for modulation of vvl
by Ken. In wild-type embryos, vvl is expressed in the de-
veloping trachea and lateral ectoderm (in a JAK/STAT-
independent manner) and in the hindgut of stage 12–
14 embryos (Figure 5A), where it requires JAK/STAT
signaling [21]. In updOS1A mutants, no vvl expression in
the hindgut can be detected ([21] and not shown), indi-
cating that this locus is a target of pathway activation.
When Ken is uniformly misexpressed throughout the
embryo, vvl expression is no longer detectable in the
hindgut (Figure 5C). Thus vvl, like trh and kni, can be
a target of Ken-mediated repression.Having established that ectopic Ken is sufficient to
downregulate vvl in the hindgut, we set out to determine
whether endogenous Ken performs a similar role. One
overlap between ken expression and regions known to
require JAK/STAT signaling are the developing posterior
spiracles, structures in which both the pathway ligand
upd and ken are simultaneously expressed (Figures 2F
and 2G). However, vvl is never detected in the posterior
spiracle primordia in wild-type embryos (Figure 5B), de-
spite JAK/STAT pathway activity induced by upd ex-
pression in these tissues [21]. Intriguingly, in a heteroal-
lelic combination of the strongest kenk11035 allele and
Df(2R)Chig320, vvl transcript was detected not only in
its normal expression domain within the hindgut (Fig-
ure 5E) but also in the posterior spiracles (Figure 5F).
This ectopic expression is initially detected from late
stage 13 and rapidly strengthens during stage 14–15.
When kenk11035/Df(2R)Chig320 embryos simultaneously
mutant for the amorphic updOS1A allele were analyzed,
upregulation of vvl in the presumptive posterior spi-
racles was never observed at the stage by which ectopic
vvl expression was first detected in the ken mutant em-
bryos (not shown). At later stages, JAK/STAT pathway
activity is required for posterior spiracle morphogenesis
[21, 24], posterior spiracles do not form, and upregu-
lated vvl is not present (Figure 5H).
These results demonstrate that Ken is not only suffi-
cient to downregulate the JAK/STAT pathway-depen-
dent expression of vvl in the hindgut, but its endogenous
expression is also necessary for vvl repression in the
posterior spiracles. In ken mutants, ectopic vvl expres-
sion in the posterior spiracles results from a derepres-
sion of endogenous STAT92E activity.
Ken as a Selective Transcriptional Regulator
The overlap between the consensus sequences bound
by STAT92E and Ken, together with the analysis of
reporters containing STAT+/Ken+ and STAT+/Ken2
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Regulate Expression of vvl
vvl expression in the hindgut (arrows in [A],
[C], [E], and [G]) of stage 13 embryos and in
the presumptive posterior spiracles (arrow-
heads in [B], [D], [F], and [H]) of stage 14 em-
bryos. Genotypes are indicated on the left
where da > ken is da-GAL4/UAS-ken and Df
is Df(2R)Chig230. Note that in wild-type em-
bryos, vvl is expressed in the hindgut (A),
but not in the posterior spiracles (outlined in
[B]). In da > ken embryos, vvl expression is
downregulated in the hindgut (C) and remains
repressed in the poorly differentiated spiracle
Anlagen (D). In kenk11035/Df(2R)Chig230 trans-
hererozygotes, vvl is detected in the hindgut
(E) as in wild-type (A) and is upregulated in
the posterior spiracles (outlined in [F]). In
updOS1A; kenk11035/Df(2R)Chig230 double mu-
tants, vvl cannot be detected in the hindgut
(G). Similarly, no expression is detected in the
region normally occupied by the presumptive
posterior spiracles that do not form properly
in this genotype (H).binding sites, indicate that Ken is likely to selectively
regulate only a subset of JAK/STAT target genes. In
this model, some target genes are regulated by binding
sites compatible with both STAT92E and Ken, while
others contain sequences to which only STAT92E canassociate. While the DNA binding site is critical in cell-
culture systems, similar proof is more difficult to estab-
lish in vivo. In particular, only a limited number of JAK/
STAT pathway target genes have been rigorously dem-
onstrated to require STAT92E binding in vivo [15, 16, 25].
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mains controlling vvl expression in the developing hind-
gut have not been identified [26, 27]. Therefore, although
our results predict that such a domain would contain
STAT+/Ken+ binding sequences, further analysis is re-
quired to confirm this hypothesis. By contrast, the regu-
latory domain of socs36E required to drive gene expres-
sion in the blastoderm, tracheal pits, and hindgut
comprises a 350 bp region containing three STAT+/
Ken+ and two STAT+/Ken2 binding sites (M.P.Z., unpub-
lished data). Although not conclusive, the presence of
STAT92E-exclusive sites in this region may explain the
inability of Ken to downregulate socs36E in vivo (Figures
4I and 4J).
Our findings also draw a parallel between Drosophila
Ken and BCL6. The data presented demonstrate that
both proteins show similar abilities to bind DNA and to
mediate transcriptional repression with some evidence
also linking BCL6 to JAK/STAT signaling as described
here. Taken together, these similarities suggest that
Ken and BCL6 represent functional orthologs of one an-
other. Given this evolutionary conservation, it is tempt-
ing to speculate that the selective regulation of JAK/
STAT pathway target genes is also conserved and may
represent a general mechanism by which the pathway
is modulated to elicit diverse developmental roles in vivo.
Although many STAT targets undoubtedly remain to be
identified, it will be intriguing to see which may also be
coregulated by Ken/BCL6-dependent mechanisms.
Experimental Procedures
Genetics
Fly stocks used were: Ore R, GMR-updD30 [5], Df(2R)Chig320 [28],
ken1 [29], ken02970 and kenk11035 [7], stat92E06342 [30], stat92EHJ [6],
sgs3-GAL4 [31], da-GAL4 [32], dome468 and dome367 [22], and
Df(1)os1A (referred to as updOS1A) [33]. All flies, larvae, and embryos
were grown at 25ºC, except for those shown in Figures 1A and 1B,
which were grown at 18ºC.
ken alleles were tested for interaction with GMR-Rho1 and GMR-
yan [34, 35]. For stat92EHJ interactions, both extra and missing wing
veins were scored as phenotypic.
DNA Constructs
ken cDNA was derived from EST clones GH12495 and LD29702. For
misexpression constructs, full-length ken ORF was amplified by
PCR and subcloned into pUAST [36]. EGFP-Ken fusions were gener-
ated by cloning into pBS-EGFPA or pBS-EGFPB [37] followed by
subcloning into pUAST and pAc5.1A (Invitrogen). To tag with GST,
Ken DNA binding domain (aa 475 to 601) was amplified and cloned
into pGEX-2T (Amersham). All PCR reactions were carried out with
PfuTurbo (Stratagene) and confirmed by DNA sequencing.
For luciferase assays, the STAT+/Ken+ sites in 2xDrafSTATwt-
TATA-luc [16] were duplicated by reinsertion of a 165 bp blunted
BamHI-XbaI fragment into a SmaI site immediately upstream of
the original binding sites to give 2x2DrafLuc(STAT+/Ken+). Quik-
Change (Stratagene) mutagenesis was used to generate STAT+/
Ken2 and STAT2/Ken2 variants resulting in 2x2DrafLuc(STAT+/
Ken2) and 2x2DrafLuc(STAT-/Ken2).
Histology
Salivary glands and embryos were prepared by standard techniques
and stained with rabbit anti-Knirps (1:200) [38], TRITC-phalloidin
(Sigma), and DRAQ5 (Biostatus). Whole-mount in situ hybridization
was performed as described previously [39] by RNA probes pre-
pared from pCRII-ken, pCRII-vvl, pFLC-1-trh, pOT2-RE54280
(BDGP), and pBS-lacZ. Embryonic cuticles were prepared as de-
scribed previously [40]. Pictures shown in Figures 2K–2N werecaptured on a Leica TCS SP2 confocal microscope in sequential
scan mode to exclude the possibility of interchannel crosstalk.
SELEX
For SELEX [13], GST-KenZnF was purified from E. coli grown in LB
medium supplemented with 1 mM ZnCl2. The binding site library con-
tained 20 bp random nucleotides. 80 ng of GST-KenZnF bound to
glutathione beads was allowed to associate with 320 ng of library
representing a complexity of approximately 103. Protein/DNA com-
plexes were allowed to form in SELEX binding buffer (20 mM HEPES
[pH 7.9], 40 mM KCl, 50 mM ZnSO4, 1.4 mM MgCl2, 0.1 mM EGTA, 5%
Glycerol, 1 mg/ml BSA, 13 Complete EDTA-free Protease Inhibitor
Cocktail [Roche], 50 mg/ml poly-dI-dC, 0.5 mM DTT, and 1 mM
PMSF) for 20 min. One-quarter of the bound and recovered DNA
was amplified by 20 cycles of PCR and purified via electrophoresis
through 4% MetaPhor agarose (Cambrex). This DNA was used as
the starting point for the next selection cycle. After 10 rounds of se-
lection, amplified DNA was subcloned into pCRII-TOPO (Invitrogen),
and 43 independent clones were sequenced. Sequences were
aligned by Gibbs Sampler and manual techniques.
Cell Culture and Transfection
S2R+ and Kc167 cells were maintained in Schneider’s Drosophila
medium (GIBCO) + 10% fetal calf serum at 25ºC. For EMSA, S2R+
cells in 10 cm dishes were cotransfected with 400 ng pUC18-Act-
GAL4, 200 ng pUAST-GFPken, 400 ng pUAST empty vector, and
1 ng pUAST-luc containing the firefly luciferase ORF. Cells were
lysed by a freeze-thaw procedure, and luciferase activity was deter-
mined to allow for comparison of transfection efficiency.
For reporter assays, 2 3 107 Kc167 cells were transfected with
200 ng of 2x2DrafLuc(STAT+/Ken+), 2x2DrafLuc(STAT+/Ken2), or
2x2DrafLuc(STAT2/Ken2) reporters together with 20 ng pAct-
Renilla and 250 ng pAc5.1A empty vector (Invitrogen). For pathway
stimulation, cells were cotransfected with 150 ng pAct-updGFP. 10
ng pAct-kenGFP was cotransfected as appropriate with a commen-
surate decrease in empty vector. After 12 hr, cells were resuspended
in fresh medium and 53 105 cells were seeded into six wells of a 96-
well plate. After 72 hr, cells were lysed and measured for Renilla and
firefly luciferase activities [17]. Values were normalized based on
Renilla luciferase activity and are shown as multiples of the unstimu-
lated level. Error bars represent standard deviation, while p values
are derived from a Student’s t test.
EMSA
To prepare a probe containing STAT92E consensus, the top-strand
GGATTTTTCCCGGAAATG and the bottom-strand GACCATTTCCG
GGAAAAA oligonucleotides were annealed to give 30 overhangs.
Similarly, oligonucleotides for Ken binding were designed as a palin-
dromic sequence containing inverted repeats of the consensus ob-
tained by SELEX. All probes were labeled with [32P]dCTP via Klenow
fragment (Roche). 5 pmols of each probe and 15 mg of total protein
were allowed to bind in SELEX binding buffer for 20 min at room tem-
perature. Supershift experiments used a 1:3000 dilution of anti-GFP
(Abcam). Complexes were resolved by nondenaturing 4% polyacryl-
amide gel electrophoresis in 0.5 3 TB (44.5 mM Tris-base, 44.5 mM
boric acid [pH 9.0]).
Supplemental Data
Supplemental Data include one figure, three tables, and Supplemental
Experimental Procedures and can be found with this article online at
http://www.current-biology.com/cgi/content/full/16/1/80/DC1/.
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